Evidence map›Paper›PMID 31583563›Full record

ArticleMolecular biology reports2019

Testis-specific Arf promoter expression in a transposase-aided BAC transgenic mouse model.

Caroline Y Sung, Yen-Ting Liu, Lynda B Bennett, Caitlin C Devitt, Stephen X Skapek

Open access · greenAbstract read
In one paragraph

Article in Molecular biology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Caroline Y Sung *Division of Hematology/Oncology, Department of Pediatrics, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA.
Yen-Ting Liu *Division of Hematology/Oncology, Department of Pediatrics, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA.
Lynda B BennettDivision of Hematology/Oncology, Department of Pediatrics, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA.
Caitlin C DevittDivision of Hematology/Oncology, Department of Pediatrics, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA.
Stephen X SkapekDivision of Hematology/Oncology, Department of Pediatrics, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA. stephen.skapek@utsouthwestern.edu.
Southwestern Medical CenterThe University of Texas Southwestern Medical Center · US

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MELANIE H. COBB · 2010 to 2026
$53.7M
Tgf Beta 2 controls p19Arf During Eye DevelopmentR01EY019942 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI SKAPEK, STEPHEN X · 2010 to 2017
$2.6M
Cancer Prevention and Research Institute of Texas RP120685-P2NCI NIH HHS CA142543NCI NIH HHS P30 CA142543NEI NIH HHS R01 EY019942
6 · The paper itself

Abstract

CDKN2A is an evolutionarily conserved gene encoding proteins implicated in tumor suppression, ocular development, aging, and metabolic diseases. Like the human form, mouse Cdkn2a encodes two distinct proteins-p16

Indexed as

Gene Expression RegulationPromoter Regions, GeneticADP-Ribosylation FactorsAnimalsCell LineChromosomes, Artificial, BacterialCyclin-Dependent Kinase Inhibitor p16Disease Models, AnimalHumansMaleMiceMice, TransgenicTestisTransposasesADP-Ribosylation FactorsCyclin-Dependent Kinase Inhibitor p16TransposasesArfBAC transgenic miceCis-regulationEye developmentInk4a

Identifiers

PMID31583563
PMCPMC6883165
OpenAlexW2978417752

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.